Macrolide
Pharmaceuticals is now
Zikani Therapeutics
We are committed to fully exploiting our platform to
develop novel Ribosome Targeting Molecules.
Who We Are
A dedicated team of scientists to improve the lives of patients suffering from serious, life-threatening conditions.
Our Goal
We are committed to fully exploiting our platform to develop novel Ribosome Targeting Molecules. To save lives and relieve patient suffering.
Join Our Team
Make a difference, and make it soon. Come join a highly motivated and focused team and help us move forward.
About Zikani Therapeutics
Zikani Therapeutics is using its innovative chemistry technology platform to develop novel Ribosome Targeting Molecules. We are focused on developing and commercializing therapeutics for patients with limited treatment options.
At Zikani, we start with a rational approach to designing Ribosome Targeting Molecules (RTMs), that expands the structural diversity of these molecules. Our goal is to develop breakthrough RTMs that are orally delivered, safe and potent for the most difficult diseases.
Become a Zikanian
Join the Zikani Team
Make a difference, and make it soon. Our groundbreaking technology provides the opportunity for rapid development of important new drugs. Come join a highly motivated and focused team.
Make a difference and, Make it Soon
OUR SCIENCE
Our Approach to Ribosome targeted drugs
Many drug classes are known to bind to all or part of the ribosome. However, many of these drugs have safety, efficacy or delivery liabilities that have prevented their full potential to be tapped
At Zikani, we start with a rational approach to designing Ribosome Targeting Molecules (RTMs), that expands the structural diversity of these molecules. Our goal is to develop breakthrough RTMs that are orally delivered, safe and potent for the most difficult diseases.
Leadership
At Zikani Therapeutics, We have a team of experts on bringing on their years of experience on developing and commercializing therapies. Our team is dedicated to improve the life of patients by developing Novel Ribosome Targeting Molecules
Let’s work together
At Zikani Therapeutics, we are eager to collaborate with academic institutions and other companies who are interested in the development of Ribosome Targeting Molecules with a focus on treating patients that have currently limited options. We believe that collaborative alliances are the most effective way to develop new medicines. If you would like to discuss working together, we’d be delighted to speak with you.
Partner With Us
we’d be delighted to speak with you
Latest News
Latest News & Events
NYTT ÅR – NYTT SCHEMA 2023!
NYTT ÅR - NYTT SCHEMA! Denna veckan startar vårt nya schema med nya pass samt en del uppdatering av våra tider! MÅL MED NYA SCHEMAT Meihem Multicenter kommer gå i riktningen att skapa Helsingborgs starkaste vardagshjältar! Ja precis, just DU ska bli starkare i kropp...
NYÅRSPAKETET 2021 FÖR MEIHEM OUTDOOR!
Kampanj och nya pass för MultiFitness!
Be our Valentine- Now and FOREVER! Nu utökar vi vårt populära Multifitness-schema till hela 26 pass i veckan. Vi lanserar fler och nya pass! Från vecka 7 finns det träning varje dag; Kl 06:30-07:15 kl 11:30-12:15 Kl 16:15-17:00 VÅRA PASS: Multifitness (Utökat)...
Call us now
Office:(617) 453-9091
We are here
480 Arsenal Way, Suite 130
Watertown, MA 02472
Drop us an email
info@Zikani.com